or
forgot password

    • cancer clinical trials in new orleans, LA

    • S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    CCOP - Ochsner

    Trial Locations
    CCOP - Ochsner
    Ochsner Cancer Institute at Ochsner Clinic Foundation
    New Orleans Cancer Institute at Memorial Medical Center
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Ochsner Cancer Institute at Ochsner Clinic Foundation

    Trial Locations
    Ochsner Cancer Institute at Ochsner Clinic Foundation
    Cancer Center at Medical Center of Louisiana - New Orleans
    Kidney Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    MBCCOP - LSU Health Sciences Center

    Trial Locations
    MBCCOP - LSU Health Sciences Center
    Medical Center of Louisiana - New Orleans
    Breast Cancer
    Rituximab in Treating Patients With Low Tumor Burden Indolent Non-Hodgkin's Lymphoma
    Ochsner Cancer Institute at Ochsner Clinic Foundation

    Trial Locations
    Ochsner Cancer Institute at Ochsner Clinic Foundation
    Medical Center of Louisiana - New Orleans
    Lymphoma
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Louisiana State University

    Trial Locations
    Louisiana State University
    Ochsner Clinic Foundation
    Louisiana State University Health Science Center
    Medical Center of Louisiana
    Ochsner Clinic CCOP
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Study of Late-Occurring Complications in Childhood Cancer Survivors
    Tulane University Health Sciences Center
    New Orleans, Louisiana 70112
    Cancer Survivor, Cardiovascular Complications, Hematopoietic/Lymphoid Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    S0106 Cytarabine and Daunorubicin w/ or w/o Gemtuzumab Followed By HD Cytarabine and Either Gemtuzumab or Nothing in de Novo AML
    MBCCOP - LSU Health Sciences Center

    Trial Locations
    MBCCOP - LSU Health Sciences Center
    Medical Center of Louisiana - New Orleans
    Leukemia
    Ixabepilone in Treating Patients With Metastatic Prostate Cancer
    CCOP - Ochsner

    Trial Locations
    CCOP - Ochsner
    Ochsner Cancer Institute at Ochsner Clinic Foundation
    Prostate Cancer
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    Children's Hospital of New Orleans

    Trial Locations
    Children's Hospital of New Orleans
    Ochsner Clinic Foundation
    Tulane Cancer Center at Tulane University Hospital and Clinic
    Kidney Cancer
    Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
    CCOP - Ochsner

    Trial Locations
    CCOP - Ochsner
    Tulane Cancer Center
    Brain and Central Nervous System Tumors
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    Louisiana State University

    Trial Locations
    Louisiana State University
    Tulane University Health Sciences Center
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer
    MBCCOP - LSU Health Sciences Center

    Trial Locations
    MBCCOP - LSU Health Sciences Center
    Medical Center of Louisiana - New Orleans
    Breast Cancer
    Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy
    MBCCOP - LSU Health Sciences Center

    Trial Locations
    MBCCOP - LSU Health Sciences Center
    Medical Center of Louisiana - New Orleans
    Metastatic Cancer, Prostate Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Louisiana State University Health Science Center

    Trial Locations
    Louisiana State University Health Science Center
    Medical Center of Louisiana
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    Tulane University Health Sciences Center
    New Orleans, Louisiana 70112
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
    CCOP - Ochsner

    Trial Locations
    CCOP - Ochsner
    Ochsner Cancer Institute at Ochsner Clinic Foundation
    Colorectal Cancer
    Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
    Tulane University Health Sciences Center
    New Orleans, Louisiana 70112
    Stage I Adrenocortical Carcinoma, Stage II Adrenocortical Carcinoma, Stage III Adrenocortical Carcinoma, Stage IV Adrenocortical Carcinoma
    Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
    MBCCOP - LSU Health Sciences Center

    Trial Locations
    MBCCOP - LSU Health Sciences Center
    Medical Center of Louisiana - New Orleans
    Prostate Cancer
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Tulane University Health Sciences Center

    Trial Locations
    Tulane University Health Sciences Center
    Louisiana State University Health Science Center
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer